- Home
- VINP vs IRMD Comparison
VINP vs IRMD Comparison
Compare VINP & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VINP
- IRMD
- Stock Information
- Founded
- VINP 2009
- IRMD 1992
- Country
- VINP Brazil
- IRMD United States
- Employees
- VINP N/A
- IRMD N/A
- Industry
- VINP Investment Managers
- IRMD Medical/Dental Instruments
- Sector
- VINP Finance
- IRMD Health Care
- Exchange
- VINP Nasdaq
- IRMD Nasdaq
- Market Cap
- VINP 714.7M
- IRMD 910.4M
- IPO Year
- VINP 2021
- IRMD 2014
- Fundamental
- Price
- VINP $11.53
- IRMD $76.81
- Analyst Decision
- VINP Strong Buy
- IRMD Strong Buy
- Analyst Count
- VINP 3
- IRMD 1
- Target Price
- VINP $13.33
- IRMD $72.00
- AVG Volume (30 Days)
- VINP 61.5K
- IRMD 66.2K
- Earning Date
- VINP 11-13-2025
- IRMD 11-03-2025
- Dividend Yield
- VINP 5.64%
- IRMD 0.89%
- EPS Growth
- VINP N/A
- IRMD 10.28
- EPS
- VINP 0.50
- IRMD 1.61
- Revenue
- VINP $153,475,995.00
- IRMD $77,635,163.00
- Revenue This Year
- VINP $67.78
- IRMD $12.53
- Revenue Next Year
- VINP $14.48
- IRMD $11.39
- P/E Ratio
- VINP $22.95
- IRMD $47.71
- Revenue Growth
- VINP 76.11
- IRMD 11.73
- 52 Week Low
- VINP $8.66
- IRMD $46.86
- 52 Week High
- VINP $11.59
- IRMD $80.65
- Technical
- Relative Strength Index (RSI)
- VINP 65.98
- IRMD 55.73
- Support Level
- VINP $11.21
- IRMD $75.75
- Resistance Level
- VINP $11.58
- IRMD $80.65
- Average True Range (ATR)
- VINP 0.27
- IRMD 2.45
- MACD
- VINP 0.00
- IRMD -0.03
- Stochastic Oscillator
- VINP 94.12
- IRMD 58.79
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.